Oncotarget was started in 2010. It is a medical journal that publishes papers on oncology. Oncotarget is free to access and is published online on a weekly basis. The journal accepts papers in other fields such as aging, cardiology, microbiology, and pharmacology even though it was started to publish articles on oncology only. The journal is also peer reviewed meaning that the content the journal publishes is relevant and of high quality.
The journal has two editors-in-chief on Facebook. They include Mikhail Blagosklonny and Andrei Gudkov. He is also a professor and Garman family chair in cell biology. Mikhail has authored over 200 articles and is the associate editor of some journals such as Autophagy and the International Journal of Cancer. Blagosklonny has been influential in the development of new and unique cancer treatment methods on scijournal.org. He has been heavily involved in the research of rapamycin and its effects on aging.
Oncotarget’s editorial board is made up of more accomplished scientists who have been instrumental in the journal’s success over the years. Some of the top papers that have been published in the journal include MET amplification and its role as a therapeutic in gastric cancer and how e-cigarettes can cause gum tissue. The Journal has maintained a high impact factor since it was started. The journal was ranked the top journal in the Oncology section last year. It also had a 5.008 impact factor in the previous year and had an average of 5.4 since it was started. The editors of the paper on bioxbio.com have worked to ensure that the journal does not recede its position as one of the top journals.
The journal hopes to accomplish some goals including allowing discoveries to be made quickly, making scientific results accessible rapidly and linking different fields at http://endnote.com/downloads/style/oncotarget. Studies can be shared quickly because it releases an issue weekly. It also allows researchers to write more articles. Oncotarget helps to widen the reach of the research that is published in its journal because it is found online and has free access. This means that people from all over the world have access to groundbreaking research which in the end might help them to make significant discoveries. The current issue and the archives of previous issues are hosted on the site.